Ipc H2020

cancer in children is rare but when it happens, clinician prescribed treatment options are not always as clear as one would hope. in fact, on average, only a quarter of oncology patients respond to the drug therapy they receive. there are many reasons for this but evidence shows that a personalized treatment plan or treatment that is based on the patient's fundamental biology could significantly enhance treatment outcomes. as it turns out, the personalized treatment plan can be as complex as the cancer itself but there is hope. a scientific consortium has recently kicked off a european commission funded research project entitled ipc (individualizedpaediatriccure). in this robust endeavor, 21 partners from eleven different countries, including nine european union member states (austria, belgium, switzerland, germany, spain, france, italy, netherlands, slovenia), along with the usa and australia will work together with the goal of giving clinicians the tools and knowledge to create indi